SOPHiA GENETICS, in collaboration with AstraZeneca, conducted a study that leveraged advanced AI-driven techniques to identify subgroups of stage IV non-small cell lung cancer (NSCLC) patients who ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...

AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

Shares of AstraZeneca PLC AZN inched up 0.35% to £118.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.

Five AstraZeneca staff have been detained in China amid claims of potential illegal activity at the British drug giant.

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British ...